IFXY yields 666666.67% · JNJ yields 2.13%● Live data
📍 IFXY pulled ahead of the other in Year 1
Combined, IFXY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IFXY + JNJ for your $10,000?
Infrax Systems, Inc. provides a series of interrelated operational management, communications, and electric power grid security related products and services that enable a unified solution for communications and applications management of the smart electric power grid. The company offers Secure Intelligent Energy Platform that offers utilities the ability to communicate with devices connected to the power grid. It also provides communication devices, including Secure Network Interface Card that resides in the utility power meter to encrypt and transport the data, such as usage, voltage, current, etc.; and collectors, concentrators, and repeaters. In addition, it offers GridMesh software that allows its hardware devices to securely join the network and communicate with each other; Utility Max (UMAX) and UMAX+ wireless solutions for electric power utilities and telephone carriers to set up a point-to-point or point-to-multipoint Ethernet links; and Grid Intrusion Management systems. Further, the company provides distribution automation solution for two-way communications from distribution devices along the power grid to the back office or substations; managed services and customer support, such as network design, deployment support, and program management; and professional services comprising engineering, construction, and project management services to the smaller utilities. Additionally, it offers asset tracker solution for the inventory management of utility smart electric power grid assets, including meters, collectors, and concentrators, as well as substation and field deployable assets. The company was formerly known as OptiCon Systems, Inc. and changed its name to Infrax Systems, Inc. in January 2010. Infrax Systems, Inc. was founded in 2004 and is based in St. Petersburg, Florida.
Full IFXY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.